These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37214749)

  • 1. Topical treatment of oral chronic graft-versus-host- disease in hematopoietic stem cell transplant recipients: A systematic review.
    Haas L; Cruz-Pamplona M
    J Clin Exp Dent; 2023 May; 15(5):e420-e427. PubMed ID: 37214749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical Corticosteroids a Viable Solution for Oral Graft Versus Host Disease? A Systematic Insight on Randomized Clinical Trials.
    Sava A; Piciu A; Pasca S; Mester A; Tomuleasa C
    Medicina (Kaunas); 2020 Jul; 56(7):. PubMed ID: 32674447
    [No Abstract]   [Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized double-blind clinical trial comparing clobetasol and dexamethasone for the topical treatment of symptomatic oral chronic graft-versus-host disease.
    Noce CW; Gomes A; Shcaira V; Corrêa ME; Moreira MC; Silva Júnior A; Gonçalves LS; Garnica M; Maiolino A; Torres SR
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1163-8. PubMed ID: 24727333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Topical Corticosteroids for Management of Oral Chronic Graft versus Host Disease.
    Elsaadany BA; Ahmed EM; Aghbary SMH
    Int J Dent; 2017; 2017():1908768. PubMed ID: 28751912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions for treating oral lichen planus: corticosteroid therapies.
    Lodi G; Manfredi M; Mercadante V; Murphy R; Carrozzo M
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD001168. PubMed ID: 32108333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Efficacy of Topical Triamcinolone in Orabase and Curcumin in Orabase in Oral Graft-Versus-Host Disease.
    Mansourian A; Bahar B; Moosavi MS; Amanlou M; Babaeifard S
    J Dent (Tehran); 2017 Nov; 14(6):313-320. PubMed ID: 29942325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of oral mucosal manifestations of chronic graft-versus-host disease: dexamethasone vs. budesonide.
    Zadik Y; Elad S; Shapira A; Shapira MY
    Expert Opin Pharmacother; 2017 Feb; 18(3):235-242. PubMed ID: 28081677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxic tacrolimus levels after application of topical tacrolimus and use of occlusive dressings in two bone marrow transplant recipients with cutaneous graft-versus-host disease.
    Olson KA; West K; McCarthy PL
    Pharmacotherapy; 2014 Jun; 34(6):e60-4. PubMed ID: 24700567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of oral Graft versus Host Disease with topical agents: A systematic review.
    Albuquerque R; Khan Z; Poveda A; Higham J; Richards A; Monteiro L; Jané-Salas E; Lopez-Lopez J; Warnakulasuriya S
    Med Oral Patol Oral Cir Bucal; 2016 Jan; 21(1):e72-81. PubMed ID: 26615510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of ruxolitinib for steroid-refractory graft-versus-host disease: Systematic review and meta-analysis of randomised and non-randomised studies.
    Zhang MY; Zhao P; Zhang Y; Wang JS
    PLoS One; 2022; 17(7):e0271979. PubMed ID: 35905125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions for bacterial folliculitis and boils (furuncles and carbuncles).
    Lin HS; Lin PT; Tsai YS; Wang SH; Chi CC
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013099. PubMed ID: 33634465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.
    Weitz M; Strahm B; Meerpohl JJ; Bassler D
    Cochrane Database Syst Rev; 2014 Feb; (2):CD009898. PubMed ID: 24569961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic hematopoietic stem cell transplant recipients and parasitic diseases: A review of the literature of clinical cases and perspectives to screen and follow-up active and latent chronic infections.
    Fabiani S; Fortunato S; Petrini M; Bruschi F
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28128496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes with CD34-Selected Stem Cell Boost for Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
    Shahzad M; Siddiqui RS; Anwar I; Chaudhary SG; Ali T; Naseem M; Ahmed TF; Ahmed Z; Khurana S; Ahmed N; Balusu R; Singh AK; Hematti P; Callander NS; Abhyankar SH; McGuirk JP; Mushtaq MU
    Transplant Cell Ther; 2021 Oct; 27(10):877.e1-877.e8. PubMed ID: 34284148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-transplantation of multipotent mesenchymal stromal cells in allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis.
    Kallekleiv M; Larun L; Bruserud Ø; Hatfield KJ
    Cytotherapy; 2016 Feb; 18(2):172-85. PubMed ID: 26794711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressants for the prophylaxis of corneal graft rejection after penetrating keratoplasty.
    Abudou M; Wu T; Evans JR; Chen X
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007603. PubMed ID: 26313245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral graft vs. host disease in children--treatment with topical tacrolimus ointment.
    Albert MH; Becker B; Schuster FR; Klein B; Binder V; Adam K; Nienhoff C; Führer M; Borkhardt A
    Pediatr Transplant; 2007 May; 11(3):306-11. PubMed ID: 17430488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.